“As a proud member of HCRN, Summit Health Cancer Center is able to provide our patients with cutting-edge trials and the finest patient care in an outpatient setting.”

William DeRosa, DO, FACP
Chair, Medical Oncology, Summit Health Cancer Center

“As a nonprofit organization with a long history of coordinating successful trials, HCRN was a great fit for UC-GENOME. The samples banked through this study will fuel innovative research in metastatic bladder cancer for years to come.”

Matthew Milowsky, MD
Section Chief, Genitourinary Oncology, UNC School of Medicine

“HCRN is an important avenue for investigators to bring new agents into clinical trials and conduct those trials across the country in an efficient and collaborative manner. This support helps us advance the care of our patients.”

Salma Jabbour, MD
Radiation Oncologist, Rutgers Cancer Institute of New Jersey

“Working with Hoosier Cancer Research Network, young investigators have a great opportunity to learn about conducting a clinical trial in a friendly and collaborative environment.”

Rachel E. Sanborn, MD, medical oncologist and co-director of Thoracic Oncology Program, Providence Cancer Institute, Portland, Ore.

“HCRN is incredibly supportive at any phase of development – from LOI to budget development, protocol development, and organizing biospecimens. They offer tremendous resources for investigators.”

Carey K. Anders, MD, medical oncologist, Duke Health, Durham, N.C.; co-chair, HCRN Breast Cancer Clinical Trial Working Group

“Hoosier Cancer Research Network fits a very unique need. My trial needed a large number of patients, and it could not be done at a single center. HCRN offers a platform that supports multi-center studies.”

Xiuning Le, MD, PhD, medical oncologist, MD Anderson Cancer Center, Houston, Texas

“I started working with Hoosier Cancer Research Network as a fellow, where I had the privilege to write a clinical trial. HCRN has been instrumental in helping me with several trials and in my professional development.”

Greg Durm, MD, medical oncologist and researcher, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Ind.

“HCRN has been a great platform for investigators to meet regularly and collaborate on important research ideas, ultimately facilitating partnerships with industry to efficiently advance the science.”

Alan Tan, MD, GU/Melanoma Medical Oncologist and Researcher

“HCRN serves as a platform for investigators to vet their ideas with other research leaders across multiple institutions and for investigators to collaborate among each other, refine protocols, and make connections with industry partners.”

Erica Stringer-Reasor, MD, associate professor, University of Alabama at Birmingham (UAB), Birmingham, AL; co-chair, HCRN Breast Cancer Clinical Trial Working Group